表紙
市場調查報告書

CountryFocus:法國的醫療、規定、醫療費償付制度狀況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

出版商 GlobalData 商品編碼 232433
出版日期 內容資訊 英文 141 Pages
訂單完成後即時交付
價格
Back to Top
CountryFocus:法國的醫療、規定、醫療費償付制度狀況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France
出版日期: 2019年04月01日內容資訊: 英文 141 Pages
簡介

本報告提供法國的醫療相關市場趨勢,及醫療費償付制度及相關法規、制度相關分析,醫藥品產業、醫療設備產業的整體結構、趨勢,醫療費償付制度等制度的概要、趨勢,醫療法規當局和各種法規概要,法國經濟、社會相關宏觀指標 (人口結構等) 等資訊彙整。

目錄

  • 摘要整理
  • 醫藥品市場概要
  • 醫療設備市場概要
  • 資本交易分析
  • 波特的五力分析
  • 市場進入
  • 法國國內的醫療環境
  • 市場機會與課題

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC0075CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of France. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2010, the French pharmaceutical market was worth $36.5B, which decreased to an estimated $33.5B in 2017 at a negative Compound Annual Growth Rate (CAGR) of 1.5%. The French medical devices market was valued at $17.7B in 2015, which increased to $19B in 2017. The market is expected to grow at a CAGR of 4% from $19.7B in 2018 to $21.2B in 2020. Regulatory reforms have led to faster and more efficient drug approval processes. The French healthcare system provides universal health coverage, healthcare reimbursement, and open healthcare access with implementation of E-health card for the French people.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the France, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Servier, Pierre Fabre and Ipsen) and profiles and SWOT analyses of the major players in the medical device market (Roche, Medtronic, Abbott, Siemens and Boston Scientific)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of France
  • Porter's five forces analysis for pharmaceutical and medical devices market of France
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the French healthcare market.

Reasons to buy

The report provides information on the healthcare, regulatory, and reimbursement landscape in the France, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Servier, Pierre Fabre and Ipsen) and profiles and SWOT analyses of the major players in the medical device market (Roche, Medtronic, Abbott, Siemens and Boston Scientific)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of France
  • Porter's five forces analysis for pharmaceutical and medical devices market of France
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the French healthcare market.

Table of Contents

  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter's Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges

Appendix

List of Tables

  • Table 1: Pharmaceutical Market, France, Sales of Patented Drug Products by Major Therapeutic Class at Ex factory Prices (%), 2017
  • Table 2: Medical Device Market, France, Revenue by Segment ($B), 2017
  • Table 3: IVD Market, France, Revenue ($M) and Market Share (%) of Major Companies
  • Table 4: Cardiovascular Devices , France, Revenue ($M) and Market Share (%) of Major Companies
  • Table 5: Hospital Supplies Market, France, Revenue ($M) and Market Share (%) of Major Companies
  • Table 6: Orthopedic Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies
  • Table 7: Ophthalmic Devices Market, France, Revenue ($M) and Market Share (%) of Major Companies
  • Table 8: Actual Clinical Benefit (ACB), France, 2018
  • Table 9: Clinical Added Value (CAV), France, 2018
  • Table 10: Rreimbursement Rates for Medical Procedures and Services Covered by Health Insurance Schemes, France, 2019
  • Table 11: Pricing Based on ASMR Level, France, 2018
  • Table 12: Patent Fees, France, 2018
  • Table 13: Trademark Fees, France, 2018
  • Table 14: Label of a Pharmaceutical Product, France, 2017
  • Table 15: Minimum particulars to appear on blisters or strips , France, 2017
  • Table 16: Minimum particulars to appear on small immediate packaging , France, 2017

List of Figures

  • Figure 1: Pharmaceutical Market, France, Revenue ($B), 2010-2017
  • Figure 2: Medical Device Market, France, Revenue ($B), 2015-2020
  • Figure 3: Number of Deals (2018-2019)
  • Figure 4: 2018-19 Deal Overview By Region
  • Figure 5: Country Profile, France, 2018
  • Figure 6: Pharmaceutical Market, France, Revenue ($B), 2010-2017
  • Figure 7: Pharmaceutical Market, France, Revenue Forecast ($B), 2018-2022
  • Figure 8: Pharmaceutical Market, France, Pharmaceutical Exports
  • Figure 9: Pharmaceutical Market, France, Top Export Partners
  • Figure 10: Pharmaceutical Market, France, Pharmaceutical Imports
  • Figure 11: Pharmaceutical Market, France, Top Import Partners
  • Figure 12: Marketing Authorizations for Generic Medicines, France, 2012-2017
  • Figure 13: Availability of Biologics in Healthcare Settings, France, 2017
  • Figure 14: Competitiveness Clusters , France, 2017
  • Figure 15: Government Funded Biosimilars, France, 2017
  • Figure 16: Pharmaceutical OTC Market, France, Revenue ($B), 2010-2017
  • Figure 17: Major OTC Drug Classes (Share%), France, 2017
  • Figure 18: Pharmaceutical Market, France, Supply Channels
  • Figure 19: Pharmaceutical Market, France, Sales of Patented Drug Products by Major Therapeutic Class at Ex factory Prices (%), 2017
  • Figure 20: Pharmaceutical Market, Major Players, France
  • Figure 21: Medical Device Market, France, Revenue ($B), 2015-2020
  • Figure 22: Medical Device Market, France, Revenue Forecast ($B), 2021-2025
  • Figure 23: Medical Device Market, France, Revenue by Segment ($B), 2018
  • Figure 24: IVD Market, France, Revenue ($B), 2015-2022
  • Figure 25: IVD Market, France, Market Share of Major Players (%)
  • Figure 26: Cardiovascular Devices Market, France, Revenue ($B), 2015-2022
  • Figure 27: Cardiovascular Devices Market, France, Market Share of Major Players (%)
  • Figure 28: Hospital Supplies, France, Revenue ($B), 2015-2022
  • Figure 29: Hospital Supplies, France, Market Share of Major Players (%)
  • Figure 30: Orthopedic Market, France, Revenue ($B), 2015-2022
  • Figure 31: Orthopedic Devices Market, France, Market Share of Major Players (%)
  • Figure 32: Ophthalmic Devices Market, France, Revenue ($B), 2015-2022
  • Figure 33: Ophthalmic Devices Market, France, Market Share of Major Players (%)
  • Figure 34: Diagnostic Market, France, Revenue ($B), 2015-2018
  • Figure 35:Diagnostic Market, France, Revenue Forecast ($B), 2019-2022
  • Figure 36: Medical Device Market - Major Players
  • Figure 37: Deal Value and Deal Count, Pharmaceutical Market, France, 2018-2019
  • Figure 38: Deal Value and Deal Count Quarterly, Pharmaceutical Market, France, 2018-2019
  • Figure 39: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, France, 2018-2019
  • Figure 40: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, France, 2018-2019
  • Figure 41: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, France, 2018-2019
  • Figure 42: M&A Deals by Therapy Area, Pharmaceutical Market, France, 2018-2019(by value and by number)
  • Figure 43: Venture Financing Deals by Therapy Area, Pharmaceutical Market France, 2018-2019(by value and by number)
  • Figure 44: Private Equity Deals by Therapy Area, Pharmaceutical Market France, 2018-2019(by value and by number)
  • Figure 45: Medical Device Market Deals, France, 2018-2019(by deal value, $M)
  • Figure 46: Medical Device Market Deals, France, 2018 -2019(by deal count)
  • Figure 47: Medical Device Market Deals Share (by deal count), France, 2018 - 2019
  • Figure 48: Medical Device Market Deals Share (by deal value), France, 2018 - 2019
  • Figure 49: Top Five Therapy Areas by Deal Value, Medical Device, France, 2018-2019
  • Figure 50: Top Five Therapy Areas by Deal Number, Medical Device, France, 2018-2019
  • Figure 51: M&A Deals by Therapy Area, Medical Device, France, 2018-2019 (by number)
  • Figure 52: Venture Financing Deals by Therapy Area, Medical Device, France, 2018-2019(by value and by number)
  • Figure 53: Private Equity Deals by Therapy Area, Medical Device France, 2018-2019(By number)
  • Figure 54: Healthcare System, France, 2018
  • Figure 55: Workflow of Healthcare System, France, 2018
  • Figure 56: Medicine Assessment Process, France, 2018
  • Figure 57: Medical Device Assessment Process, France, 2018
  • Figure 58: Network of Public Insurance Providers, France, 2018
  • Figure 59: Revenue Structure of CNAM, France, 2017
  • Figure 60: Funding by Mutuals, France, 2018
  • Figure 61: Funding by Provident Institutions, France, 2018
  • Figure 62: Funding by Insurance Companies, France, 2018
  • Figure 63: OOP Expenditure (% of total expenditure on health), France, 2010-2016
  • Figure 64: Annual Rate of Change (%), Health Price Index, France, 2010-2019
  • Figure 65: Pricing Process, France, 2019
  • Figure 66: The Evolution of the Price of Drugs, France, 2018
  • Figure 67: ANSM, Organizational Structure, France, 2019
  • Figure 68: National Procedure, France, 2017
  • Figure 69: Centralized Procedure, 2018
  • Figure 70: Decentralized Procedure, 2018
  • Figure 71: Mutual Recognition Procedure, 2018
  • Figure 72: Conformity Assessment of Class I Medical Devices, EU, 2018
Back to Top